
CLBT Stock Forecast & Price Target
CLBT Analyst Ratings
Bulls say
Cellebrite DI is a global leader in providing AI-powered digital investigative and intelligence solutions, specifically designed for law enforcement, defense, and intelligence agencies. Despite recent management changes, the company has consistently delivered strong free cash flow margins and is well-positioned for future growth with new products like Genesis. While near-term sales cycles are expected to lengthen, the company's loyal customer base and purpose-built platform mitigate competitive risks. With a recent pullback in stock price, shares are attractive, trading at only ~10.5x EV/CY27 FCF compared to peers at ~19-22x. Additionally, the company's high exposure to the public sector and potential technological risks should be considered, but we believe these risks are mitigated by Cellebrite's strong market position and ongoing innovation.
Bears say
Cellebrite DI is facing multiple challenges that have resulted in decreased ARR and revenue growth. These challenges include: longer sales cycles and lower expansion from Inseyets conversions, missed revenue guidance, and dependence on law enforcement and government agencies for a large portion of its revenue. Additionally, potential risks from changes in public sentiment towards law enforcement and fluctuations in foreign currency could impact the company's financial results. Despite the potential for growth from new products like Genesis, the lowered growth outlook and recent stock market corrections present a negative outlook on the company's stock.
This aggregate rating is based on analysts' research of Cellebrite DI Ltd and is not a guaranteed prediction by Public.com or investment advice.
CLBT Analyst Forecast & Price Prediction
Start investing in CLBT
Order type
Buy in
Order amount
Est. shares
0 shares